UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006914 |
|---|---|
| Receipt number | R000008172 |
| Scientific Title | postmarketing surveillance For Investigating success in achieving clinical and functional Remission and Sustaining efficacy with Tocilizumab in BIOlogics naive RA patients |
| Date of disclosure of the study information | 2011/12/22 |
| Last modified on | 2018/01/22 11:18:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/12/20 12:00:47 | ||
| 2 | Update | 2012/01/16 17:59:57 | Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2012/01/16 18:01:33 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2012/01/16 18:02:50 | Recruitment status |
|
| 5 | Update | 2013/01/15 10:43:34 | Recruitment status Last follow-up date |
|
| 6 | Update | 2016/07/05 15:36:23 | Date of closure to data entry |
|
| 7 | Update | 2016/07/07 14:47:10 | Last follow-up date |
|
| 8 | Update | 2016/07/07 14:56:05 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person TEL Name of primary person or sponsor Organization |
|
| 9 | Update | 2016/07/07 14:58:59 | Date trial data considered complete Date analysis concluded |
|
| 10 | Update | 2016/07/08 08:25:21 | Recruitment status |
|
| 11 | Update | 2018/01/22 11:18:50 | Publication of results |
